Over 86% of Regina Miracle Staffers Suitable for Inoculation in the Five Plants of Hai Phong City, Vietnam Vaccinated

11/18/2021 | Corporate

Over 86% of Regina Miracle Staffers Suitable for Inoculation in the Five Plants of Hai Phong City, Vietnam Vaccinated

Together with 100% Workforce in China Suitable for Vaccination Already Jabbed

Well-positioned to Capture Strong Orders Demand from International Brand Partners

(16 September 2021, Hong Kong) Regina Miracle International (Holdings) Limited, a world-leading innovative design manufacturer (“IDM”) of intimate wear, (“Regina Miracle” or the “Company”, together with its subsidiaries the “Group”) (stock code: 2199) arranged on-site COVID-19 vaccination for employees at its plants in Vietnam Singapore Industrial Park (“VSIP”) in Hai Phong City, Vietnam during 8 to 13 September 2021. As of today, approximately 86% of its about 37,000 employees working in five plants, excluding those certificated as not suitable to take the shots.

Stable operation in Vietnam enables the Group to fully capture the strong order demands

For Regina Miracle, Vietnam is an important production base, hence it has closely monitored potential risks brought by the COVID-19 pandemic. Fortunately, the proper epidemic containment measures implemented in Hai Phong City and its surrounding area enabled the Group’s normal operations of its six plants in Hai Phong City and Hung Yen City since the Chinese New Year. As the orders demand from international brand partners recovered in the second half of last year, the Group has since then resumed its recruitment in Vietnam. The satisfactory recruitment progress and high staff stability enable the Group maintain its steady production capability in the country. Fully supported by the Vietnam Government and Vietnamese Health Ministry, the Group has successfully arranged the COVID-19 vaccination for approximately 86% of suitable employees in its production base in Hai Phong City, which ensures a safe working environment to the Group’s workforce and in turn a stable operation of the Group in the country.

While for the Group’s facilities in Shenzhen, China, 100% of eligible staff are vaccinated, majority of the vaccination were done through the on-site vaccination program encouraged by the Group during May to July this year. Regina Miracle is doing its best to support the restoration of safety and normality of the community it has operations in.

Mr. YY Hung, Chairman, CEO and Executive Director of Regina Miracle, said: “At Regina Miracle, our people’s health and safety are of our top priority. While the Group continued with the stable operation of its Vietnam plants, as part of Vietnam government’s outreach COVID-19 vaccination programme announced in late August, we are very pleased with the high vaccination rate achieved at our production base in VSIP, Hai Phong City, Vietnam within a short period of time. Together with the high vaccination rate already attained in our China plant, we have built a protective barrier for our colleagues against COVID-19 and in turn for our production capability. Looking ahead, we will focus on using our full production capacities in both Vietnam and China to capture the strong order demands from our international brand partners. We are well-positioned to do that and have full confidence in seeing our business gather growth momentum in the foreseeable future.”

Regina Miracle arranges on-site COVID-19 vaccination for employees at its plants in VSIP in Hai Phong City, Vietnam

維珍妮於越南海防市之五個廠房的合適員工已接種新冠疫苗

09/06/2021 | 企業

維珍妮於越南海防市之五個廠房的合適員工已接種新冠疫苗

連同中國內地 100%合適員工 的接種率
準備就緒全面把握來自國際品牌合作夥伴的強勁訂單需求

(2021年 9月 16日 香港訊 )— 全球領先的貼身內衣創新設計製造商 (「 IDM」) 維珍妮國際(控股)有限公司 (「維珍妮」或「公司」,連同附屬公司,統稱「集團」)(股份代號 2199於 9月 8至 13日 在 越南 海防市 越南新加坡工業園(「 VSIP」)內 的廠房為員工安排現場 COVID-19疫苗接種 。截至今天, 五個廠房約 37,000名員工 撇除不適合接種人士 已有 約 86%員工接種 新冠狀病毒病(「 COVID-19」) 疫苗。

越南廠房營運穩定 全面把握強勁訂單需求

越南作為 維珍妮 重要的生產基地, 集團一直 密切監察 及評估 疫情 為 當地 產 能 帶來的潛在風險。猶幸 自農曆新年以來, 越南海防以及其周遭省份疫情控制理想 維珍妮於越南 海防以及興安的六個廠房均一直保持正常營運 。 自國際品牌夥伴訂單需求自去年下半年恢復以來, 集團在當地招工及員工穩定情況亦一直保持理想,令集團在越南的產能保持穩定 。 是次在越南政府及越南衛生部的全力支持下,集團海防生產基地成功為約 86%合適員工接種 COVID-19疫苗 不僅
能 確保員工擁有安全的工作環境, 更 保障 集團在該國的 生產 營運 維持穩定 。

而集團位於 中國 深圳的廠房 適合接種 員工的接種率已達100%,其中大部分員工的疫苗亦是通過集團於今年 5至 7月鼓勵 推行 的 COVID-19 疫苗現場接種計劃 接種 集團 矢志為其經營業務的社區早日恢復正常生活出一分力。

維珍妮主席、首席執行官兼執行董事洪游奕先生表示:「 員工的健康和安全對維珍妮來說至關重要。 在越南廠房營運持續保持穩定營運的基礎上,集團 配合越南政府 8 月下旬宣布的COVID-19 疫苗接種計劃, 我們 很高興旗下越南海防市 VSIP內 的 生產基地 於短時間內已達致高疫苗接種率。 加上集團在中國內地早已達致非常理想的高疫苗接種率, 我們 不但 為 同事建立了一個預防 COVID-19的屏障, 更有助保障 我們 維持穩健的 生產能力。展望未來,我們將專注於 全面善 用我們在越南 及中國內地 的產能,以 抓緊 國際品牌合作夥伴的強勁訂單需求。我們已準備就緒 ,並對維持業務增長勢頭充滿信心。」

維珍妮在其越南海防市廠房為員工安排現場 COVID-19 疫苗接種